picoplatin

DRUG7 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Jonsson Comprehensive Cancer Center, Poniard Pharmaceuticals

Conditions

Bladder CancerBreast CancerColorectal CancerGastrointestinal NeoplasmHead and Neck CancerHormone Refractory Prostate CancerLung CancerLymphoma

Phase 1

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

CompletedNCT00016172

Memorial Sloan Kettering Cancer CenterLymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Start: 2000-11-30End: 2002-04-30Updated: 2013-06-18

A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer

Poniard PharmaceuticalsHormone Refractory Prostate Cancer

Start: 2006-06-30End: 2010-07-31Target: 95Updated: 2009-01-21

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

CompletedNCT00465725

Poniard PharmaceuticalsBladder Cancer, Breast Cancer, Colorectal Cancer +6

Start: 2007-04-30End: 2009-07-31Target: 18Updated: 2009-09-24

Cardiac Safety Assessment Study of Picoplatin in Solid Tumors

Poniard PharmaceuticalsSolid Tumors

Start: 2008-06-30End: 2009-07-31Target: 40Updated: 2009-09-24

Phase 2

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

Jonsson Comprehensive Cancer CenterLung Cancer

Updated: 2013-12-19

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

CompletedNCT00116610

Poniard PharmaceuticalsSmall Cell Lung Cancer

Start: 2005-06-30End: 2008-03-31Target: 75Updated: 2009-01-21

Phase 3

Study of Picoplatin Efficacy After Relapse

Poniard PharmaceuticalsSmall Cell Lung Cancer

Start: 2007-04-30Target: 399Updated: 2009-04-14